global dermatology market

Recent Highs & Lows in the Vaccine Market 

14 January 2020
Pharma

global dermatology market

With the emergence of new health technology and advances in vaccines, manufacturers and key stakeholders can position themselves to generate big returns in the coming years. However, getting ahead of the competition will require having the right tools at your disposal, which is why Visiongain is proud to offer extensive vaccine market forecasts, as well as reports from other verticals like pharma, dermatology, and more. 

Below, we’ve compiled some of the latest market info and emerging trends for your perusal. 

Market Growth & Consolidation Factors 

The global vaccine market is experiencing rapid growth in several sectors, one of which is the Chinese market, where expanding immunization programs are calling for increased vaccines. As newly industrialized or lesser developed countries begin constructing more comprehensive vaccine and immunization technologies, there are a lot of opportunities for investors and drug developers to be at the forefront. 

Another lucrative area in the global vaccination market is creating vaccines for older individuals since many children have already received the most up-to-date vaccines. Disease prevention in both old and young can help create big improvements in the long-term since vaccinations are a fraction of the cost of treating actual diseases and chronic disorders. 

Vaccine Shortages & Other Industry Concerns 

One important thing to note in the years ahead is that, due to the success of vaccines, like those that treat polio, smallpox, and measles, there is actually a shortage of some vaccines. In a recent article on the subject, experts said it was “ironic,” stating that vaccines have done such a great job at reducing risks people often forget how necessary they are. Some of the most pressing vaccine shortages include that for varicella, the pneumococcal conjugate vaccine (PCV), which guards against pneumonia, meningitis, and ear infections, as well as tetanus vaccines. 

This leaves much room for growth, in particular the increased manufacturing of important vaccines for patients around the world. Some in the industry have called for changes in legislation that would enable animal testing when human testing isn’t possible as a solution. Other have proposed solutions to the shortage like added oversight, centralization, and accountability at the governmental level. 

Let Visiongain help you handle emerging trends in the vaccine market! 

Visiongain can provide you with the necessary information to make informed decisions in the coming years. We offer in-depth reports in the pharmaceutical and medical industry, everything from global dermatology market breakdowns to medical device forecasts, and more. 

For more than 20 years, the team from Visiongain has been helping key stakeholders in a variety of industries excel. With more than 1,500 reports across over 18 market verticals, it’s easy to find the insight you need. 

Call today at +44 (0) 20 7549 9987 or visit us online for more information. 

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever